Is there a need to redefine the upper normal limit of TSH?

European Journal of Endocrinology
G BrabantWilmar Wiersinga

Abstract

Mild forms of hypothyroidism--subclinical hypothyroidism--have recently been discussed as being a risk factor for the development of overt thyroid dysfunction and for a number of clinical disorders. The diagnosis critically depends on the definition of the upper normal limit of serum TSH as, by definition, free thyroxine serum concentrations are normal. Cut-off levels of 4-5 mU TSH/l have been conventionally used to diagnose an elevated TSH serum concentration. Recent data from large population studies have suggested a much lower TSH cut-off with an upper limit of 2-2.5 mU/l but application of strict criteria for inclusion of subjects from the general population studies aiming at assessing TSH reference intervals (no personal or family history of thyroid disease, no thyroid antibodies and a normal thyroid on ultrasonography) did not result in an unequivocal upper limit of normal TSH at 2.0-2.5 mU/l. When summarizing the available evidence for lowered upper TSH cut-off values and their potential therapeutic implications there is presently insufficient justification to lower the upper normal limit of TSH and, for practical purposes, it is still recommended to maintain the TSH reference interval of 0.4-4.0 mU/l. Classifying subjec...Continue Reading

Citations

Jan 25, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Laszlo Hegedüs
May 29, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Kris PoppeDaniel Glinoer
Jul 18, 2008·Thyroid : Official Journal of the American Thyroid Association·Kris PoppeBrigitte Velkeniers
Jul 25, 2008·Thyroid : Official Journal of the American Thyroid Association·Robert BurnsPeter P A Smyth
Dec 1, 2010·Thyroid : Official Journal of the American Thyroid Association·Nicole S NaderSeema Kumar
Nov 18, 2008·European Heart Journal·Henry VölzkeMarcus Dörr
Aug 25, 2007·BMJ : British Medical Journal·Joanna Girling, Catherine Nelson-Piercy
Jan 11, 2013·Journal of Thyroid Research·Rudolf Hoermann, John E M Midgley
Nov 4, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Carla EstaquioKatia Castetbon
Feb 1, 2012·Drug Design, Development and Therapy·Ali J ChakeraBijay Vaidya
Dec 29, 2011·Internal and Emergency Medicine·Anna BoggioAdriana Branchi
Jul 25, 2007·Journal of Endocrinological Investigation·M Niedziela
Mar 20, 2010·European Journal of Endocrinology·Rudolf HoermannRolf Larisch
Aug 6, 2009·Environmental Health Perspectives·Mark D MillerR Thomas Zoeller
Apr 29, 2014·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Rong HuangWei Liu
Aug 19, 2008·Wiener klinische Wochenschrift·Christian BieglmayerWolfgang Zechmann
Jun 3, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·You-Juan PeiGui Chun Han
Feb 15, 2012·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Cem CelikMurat Yılmaz
Aug 4, 2012·Endocrine Research·Marina A SviridonovaGalina A Melnichenko
Mar 24, 2011·Scandinavian Journal of Clinical and Laboratory Investigation·Camilla Schalin-JänttiEsa Hämäläinen
Dec 18, 2013·La Presse médicale·Michèle d'HerbomezJean-Louis Wémeau
Oct 6, 2012·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Vanessa Sarzosa Terán, María Augusta Astudillo Calle
Jun 29, 2007·Journal de gynécologie, obstétrique et biologie de la reproduction·J-L Schlienger, B Langer
Nov 30, 2010·European Journal of Internal Medicine·Annemieke RoosStephan J L Bakker
May 19, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·C DechanetH Dechaud
Nov 11, 2015·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M LaclaustraJ A Casasnovas
Dec 5, 2015·Frontiers in Endocrinology·Rudolf HoermannJohannes W Dietrich
Jun 19, 2007·Best Practice & Research. Clinical Endocrinology & Metabolism·Josef Köhrle
Jan 9, 2015·Nuklearmedizin. Nuclear Medicine·Rolf LarischR Hoermann
Jun 24, 2014·Metabolomics : Official Journal of the Metabolomic Society·Carolin JourdanHenry Völzke
Feb 17, 2007·Clinical Endocrinology·Kris PoppeDaniel Glinoer
Jun 19, 2012·Clinical Endocrinology·Kalani M Kahapola-ArachchigeJohn P Walsh
Aug 18, 2010·American Journal of Reproductive Immunology : AJRI·Na Young KimJoanne Kwak-Kim
Sep 17, 2010·Cancer·Manuela SchmidingerChristoph C Zielinski
May 8, 2010·Clinical Endocrinology·Stephan RuhlaMatthias Möhlig
Feb 23, 2013·International Journal of Endocrinology·L PacificoC Chiesa
Aug 7, 2008·Clinical Chemistry and Laboratory Medicine : CCLM·Lennart Friis-Hansen, Linda Hilsted

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.